Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)
China
· Delayed Price · Currency is CNY 29.58
-0.30 (-1.00%)
At close: May 9, 2025, 2:57 PM CST
SHE:001367 Revenue
Zhejiang Haisen Pharmaceutical had revenue of 118.48M CNY in the quarter ending March 31, 2025, with 2.32% growth. This brings the company's revenue in the last twelve months to 474.19M, up 16.71% year-over-year. In the year 2024, Zhejiang Haisen Pharmaceutical had annual revenue of 471.51M with 18.63% growth.
Revenue (ttm)
474.19M
Revenue Growth
+16.71%
P/S Ratio
6.41
Revenue / Employee
715.22K
Employees
663
Market Cap
3.04B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |